30 Apr 2018

1st Quarter 2018

We have completed randomizing 23 subjects to replace subjects who did not fulfill critical eligibility criteria. Some sites received IRB confirmation to continue recruitment.

ASCOLT Data Monitoring Committee (DMC) has met on Jan 4 2018 and concluded with no concerns about toxicity related to treatment.